Zimmer Biomet Holdings, Inc. (ZBH) stock analysis
In our weekly check, Zimmer Biomet Holdings, Inc. is graded B (A to F). Of 25 checks on debt, profit, cash flow and trend: 18 pass, warnings: 5, red flags: 2.
About Zimmer Biomet Holdings, Inc.
Zimmer Biomet Holdings, Inc. is a Healthcare company (Medical Devices) based in the United States, listed on NYSE as ZBH.
What our checks show for ZBH
Red flags
- The stock has fallen as much as 65% from a peak. Would you have held through that?
- Recovering from its deepest fall took about 4.7 years.
Warning signs
- Net debt is 3.1x a year of EBITDA (debt/equity 0.59). That limits room in a downturn and raises refinancing risk.
- The gross margin fell by 1.6 points, to 69.7%: costs are rising faster than prices.
- Analysts expect only about 3.4% a year of growth in revenue.
- The net margin is only 9%: little room if costs rise.
- Return on capital (ROCE) is only 6.5%.
Strengths
- The net margin rose by 3.1 points over 5 years, to 9%.
- Operating cash flow is 2.21x net profit: the profit arrives as real cash.
- Analysts expect earnings per share to grow about 48.3% a year over the next years.
- Analysts expect the net margin to improve by 10.7 points from today's 9%.
- Earnings per share grew 53.4% a year over the last 3 years.
- Net profit grew 49.1% a year over the last 3 years.
Next earnings report: 2027-02-09
Similar companies
GKOS · SNN · PEN · DXCM · ALGN · PODD
Questions
What grade does Zimmer Biomet Holdings, Inc. (ZBH) have?
In our weekly check, Zimmer Biomet Holdings, Inc. is graded B (A to F). Of 25 checks on debt, profit, cash flow and trend: 18 pass, warnings: 5, red flags: 2. The grade is a risk check, not a buy or sell recommendation.
What are the main risks of ZBH stock?
This week's biggest flags for Zimmer Biomet Holdings, Inc.: Deep past fall, Slow recovery after falls, High debt. In total 7 of 25 checks show a warning or a red flag.
What does Zimmer Biomet Holdings, Inc. do?
Zimmer Biomet Holdings, Inc. is a Healthcare company (Medical Devices) based in the United States, listed on NYSE as ZBH.
When does Zimmer Biomet Holdings, Inc. report earnings next?
The next earnings report is expected on 2027-02-09. We re-run the checks every week, so the grade can change after it.
The grade is a risk check, not a price forecast, and not investment advice. In our 10-year test (S&P 500, 2016-2026), stocks we graded A or B fell more than 30% 2-3 times less often than D or F, without a lower average return.
Updated 2026-11-14
Open the full analysis